Neoplasms

All Conditions

Symptoms and General Pathology

Skin and Connective Tissue Diseases

Carcinoma

Carcinoma, Ductal

Hyperplasia

Carcinoma in Situ

Carcinoma, Intraductal, Noninfiltrating

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Adenocarcinoma

Breast Neoplasms

Breast Carcinoma In Situ

Patients in this arm underwent to an initial sequence of sampling (less than 4 g of tissue sampled)

Patients in this arm will undergo a second sequence of biopsy samples (at least 4g sampled)

at least 4g of tissue sampled (excisional biopsy)

Vacuum-assisted excisional biopsy

biopsy with less than 4 g of tissue sampled

Not excisional biopsy

Luca Nicosia, MD

Claudia Sangalli, MSc

The goal of this prospective cohort study is to evaluate the possibility of vacuum-assisted excisional biopsy (VAE) to completely remove the pathology in case of small lesions for Atypical Ductal Hyperplasia (ADH) and low-intermediate grade Ductal Carcinoma in Situ (DCIS).

Surgery is the current standard of care of breast lesions like the Ductal Carcinoma In Situ (DCIS) and the Atypical Ductal Hyperplasia (ADH). However, the survival benefit of surgical resection in patients with such lesions appears to be low, especially for ADH and low-grade DCIS where comorbidity of surgery and prior depression have been reported as important factors related to worse quality of life in these women.

Patients with suspicious breast lesions (BIRADS\>3) who are candidates for vacuum assisted breast biopsy will be prospectively select and enroll if the radiological lesion diameter is less than 15 mm.

The investigators will select those patients in whom after an initial sequence of sampling (12 cores), and will check the complete macroscopic removal of the lesion (with radiograms of the biopsied part of the breast). Those patients (complete macroscopic removal, with real-time verification during the procedure) will be randomized into two groups. A first group of patients will finish the biopsy procedure after the first collection sequence (12 cores, 3 grams of tissue taken and complete macroscopic removal). A second group of patients (randomized subdivision) will undergo a second sequence of biopsy samples (other 4 cores and 1 gram of tissue taken) in the same session: the material collected will be sent separately to the pathologist.

Excisional Vacuum-Assisted Breast Biopsy

Excisional Vacuum-Assisted Breast Biopsy (VAE): Application to Avoid Surgery in Atypical Ductal Hyperplasia and Low/Intermediate Grade Ductal Carcinoma in Situ of the Breast

Comparison of the percentage of patients with a lack of pathology (also in situ) at the surgery between the two groups

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Excisional Vacuum-Assisted Breast Biopsy	NCT05932758	Atypical Ductal... Ductal Carcinom...	Vacuum-assisted... Not excisional ...	18 Years -	European Institute of Oncology
Excisional Vacuum-Assisted Breast Biopsy	NCT05932758	Atypical Ductal... Ductal Carcinom...	Vacuum-assisted... Not excisional ...	18 Years -	European Institute of Oncology

Spots Global Cancer Trial Database for not excisional biopsy